Pages that link to "Q57618625"
Jump to navigation
Jump to search
The following pages link to Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma (Q57618625):
Displaying 50 items.
- Role of Hyperthermia in Breast Cancer Locoregional Recurrence: A Review (Q26753882) (← links)
- Current state of the art of regional hyperthermia treatment planning: a review (Q26783500) (← links)
- Transient mild hyperthermia induces E-selectin mediated localization of mesoporous silicon vectors in solid tumors (Q27330421) (← links)
- Mild hyperthermia enhances transport of liposomal gemcitabine and improves in vivo therapeutic response. (Q27342656) (← links)
- DCE-MRI and IVIM-MRI of rabbit Vx2 tumors treated with MR-HIFU-induced mild hyperthermia (Q30388286) (← links)
- Shedding light on nanomedicine. (Q30447871) (← links)
- Adaptive Real-Time Closed-Loop Temperature Control for Ultrasound Hyperthermia Using Magnetic Resonance Thermometry (Q30466511) (← links)
- Feasibility of concurrent treatment with the scanning ultrasound reflector linear array system (SURLAS) and the helical tomotherapy system (Q30481247) (← links)
- Microwave thermal imaging of scanned focused ultrasound heating: phantom results (Q30484047) (← links)
- Lysosomal rerouting of Hsp70 trafficking as a potential immune activating tool for targeting melanoma (Q30530764) (← links)
- Status of hyperthermia in the treatment of advanced liver cancer (Q30704873) (← links)
- Therapy of cutaneous metastases of malignant melanoma (Q30828035) (← links)
- Hyperthermia Is Now Included in the NCCN Clinical Practice Guidelines for Breast Cancer Recurrences: An Analysis of Existing Data (Q30981785) (← links)
- Rationale of hyperthermia for radio(chemo)therapy and immune responses in patients with bladder cancer: Biological concepts, clinical data, interdisciplinary treatment decisions and biological tumour imaging. (Q31070048) (← links)
- Tumor vascular permeabilization using localized mild hyperthermia to improve macromolecule transport (Q31144268) (← links)
- Enhancement of thermoradiotherapy by glucose administration for superficial malignant tumours (Q32063714) (← links)
- Role of HIF-1α in response of tumors to a combination of hyperthermia and radiation in vivo (Q32174462) (← links)
- Reirradiation combined with hyperthermia in recurrent breast cancer results in a worthwhile local palliation (Q33177386) (← links)
- Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura--a single-institution experience with 189 patients (Q33177646) (← links)
- Heating the patient: a promising approach? (Q33184112) (← links)
- Interstitial Microwave Thermal Therapy for Prostate Cancer (Q33195101) (← links)
- The Kadota Fund International Forum 2004--clinical group consensus (Q33320286) (← links)
- Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice (Q33341574) (← links)
- Hyperthermia induced NFkappaB mediated apoptosis in normal human monocytes (Q33409562) (← links)
- Hyperthermia classic commentary: 'Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology' by J. Overgaard, D. Gonzalez Gonzalez (Q33492472) (← links)
- Ultrasound technology for hyperthermia (Q33719989) (← links)
- Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications. (Q33757142) (← links)
- Status of clinical hyperthermia (Q33801082) (← links)
- Comparison of genomics and functional imaging from canine sarcomas treated with thermoradiotherapy predicts therapeutic response and identifies combination therapeutics (Q33811587) (← links)
- Quality control of superficial hyperthermia by treatment evaluation (Q33875582) (← links)
- Gold-Based Magneto/Optical Nanostructures: Challenges for In Vivo Applications in Cancer Diagnostics and Therapy (Q33937164) (← links)
- Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer (Q33994410) (← links)
- Management of regional metastases (Q34067628) (← links)
- Comparison of oxidized porous silicon with bare porous silicon as a photothermal agent for cancer cell destruction based on in vitro cell test results. (Q34096953) (← links)
- Concurrent versus sequential application of ferromagnetic hyperthermia and 125I brachytherapy of melanoma in an animal model (Q34163539) (← links)
- Thermal dose fractionation affects tumour physiological response (Q34340122) (← links)
- Design and evaluation of a hybrid radiofrequency applicator for magnetic resonance imaging and RF induced hyperthermia: electromagnetic field simulations up to 14.0 Tesla and proof-of-concept at 7.0 Tesla. (Q34684765) (← links)
- Hyperthermia in combined treatment of cancer (Q34766163) (← links)
- Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy (Q34766341) (← links)
- Update on the treatment of advanced cervical cancer (Q34882121) (← links)
- Regulators of homologous recombination repair as novel targets for cancer treatment. (Q35200273) (← links)
- Cancer Theranostics with Near-Infrared Light-Activatable Multimodal Nanoparticles (Q35387377) (← links)
- Hyperthermia Sensitizes Glioma Stem-like Cells to Radiation by Inhibiting AKT Signaling (Q35463653) (← links)
- Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry. (Q35632050) (← links)
- Introduction: thermal ablation therapy. (Q36022031) (← links)
- A method to correct for temperature dependence and measure simultaneously dose and temperature using a plastic scintillation detector. (Q36185415) (← links)
- FDTD analysis of a noninvasive hyperthermia system for brain tumors (Q36334975) (← links)
- Radiation therapy for cutaneous melanoma (Q36340608) (← links)
- Reduction of hypoxic cells in solid tumours induced by mild hyperthermia: special reference to differences in changes in the hypoxic fraction between total and quiescent cell populations (Q36431038) (← links)
- Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study (Q36454797) (← links)